These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12559892)

  • 1. Design of clinical trials in cystic fibrosis.
    Southern KW; Smyth RL
    Lancet; 2003 Jan; 361(9354):349-50; aurhor reply 350. PubMed ID: 12559892
    [No Abstract]   [Full Text] [Related]  

  • 2. Azithromycin for cystic fibrosis.
    Southern KW; Barker PM
    Eur Respir J; 2004 Nov; 24(5):834-8. PubMed ID: 15516680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin for improving pulmonary function in cystic fibrosis.
    Carr RR; Nahata MC
    Ann Pharmacother; 2004 Sep; 38(9):1520-4. PubMed ID: 15213312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of azithromycin in patients with cystic fibrosis.
    Yousef AA; Jaffe A
    Paediatr Respir Rev; 2010 Jun; 11(2):108-14. PubMed ID: 20416547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has the time come to prescribe azithromycin in cystic fibrosis patients?
    McCormack JG; Bell SC
    Intern Med J; 2005 Feb; 35(2):73-4. PubMed ID: 15705133
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term azithromycin may improve lung function in children with cystic fibrosis.
    Jaffé A; Francis J; Rosenthal M; Bush A
    Lancet; 1998 Feb; 351(9100):420. PubMed ID: 9482305
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis.
    Saiman L; Mayer-Hamblett N; Campbell P; Marshall BC;
    Am J Respir Crit Care Med; 2005 Oct; 172(8):1008-12. PubMed ID: 16040785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin, the multidrug-resistant protein, and cystic fibrosis.
    Altschuler EL
    Lancet; 1998 Apr; 351(9111):1286. PubMed ID: 9643772
    [No Abstract]   [Full Text] [Related]  

  • 9. How long should we maintain long-term azithromycin treatment in cystic fibrosis patients?
    Willekens J; Eyns H; Malfroot A
    Pediatr Pulmonol; 2015 Jan; 50(1):103-4. PubMed ID: 24464958
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: possible role of mycoplasma infection.
    Janahi IA; Abdulwahab A; Elshafie Sittana S; Bush A
    J Cyst Fibros; 2005 Mar; 4(1):71-3. PubMed ID: 15752685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do cystic fibrosis patients on azithromycin need electrocardiogram monitoring?
    Sharpton R; Condren M; O'Neal K; Lloyd A; McIntosh H
    Pulm Pharmacol Ther; 2017 Apr; 43():55-56. PubMed ID: 28219728
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining a pulmonary exacerbation in cystic fibrosis.
    Rosenfeld M; Emerson J; Williams-Warren J; Pepe M; Smith A; Montgomery AB; Ramsey B
    J Pediatr; 2001 Sep; 139(3):359-65. PubMed ID: 11562614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
    Wong C; Jayaram L; Karalus N; Eaton T; Tong C; Hockey H; Milne D; Fergusson W; Tuffery C; Sexton P; Storey L; Ashton T
    Lancet; 2012 Aug; 380(9842):660-7. PubMed ID: 22901887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of trachoma: are we in danger of being blinded by the randomised controlled trial?
    Wright HR; Keeffe JE; Taylor HR
    Br J Ophthalmol; 2006 Nov; 90(11):1339-42. PubMed ID: 17057171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials.
    Mayer-Hamblett N; Saiman L; Lands LC; Anstead M; Rosenfeld M; Kloster M; Fisher L; Ratjen F
    Contemp Clin Trials; 2013 Sep; 36(1):99-105. PubMed ID: 23770109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis.
    Roberts MC; Soge OO; No DB
    J Antimicrob Chemother; 2011 Jan; 66(1):100-4. PubMed ID: 21081549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to letter.
    Ratjen F; Anstead M; Lands L; Mayer-Hamblett N; Saiman L
    Pediatr Pulmonol; 2015 Jan; 50(1):105. PubMed ID: 24700677
    [No Abstract]   [Full Text] [Related]  

  • 18. Azithromycin in cystic fibrosis.
    Kastelik JA; Peckham DG; Conway S
    Eur Respir J; 2005 Apr; 25(4):771; author reply 771-2. PubMed ID: 15802355
    [No Abstract]   [Full Text] [Related]  

  • 19. Description and status of the azithromycin and coronary events study (ACES).
    Jackson LA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S579-81. PubMed ID: 10839763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis.
    Florescu DF; Murphy PJ; Kalil AC
    Pulm Pharmacol Ther; 2009 Dec; 22(6):467-72. PubMed ID: 19328860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.